Literature DB >> 557703

[Immunoblastic lymphadenopathy--malignant neoplasia or hyperimmune reaction? (author's transl)].

A Schoengen, H Feyen, O Haferkamp, H Heimpel, B Kubanek.   

Abstract

Six patients have been observed which exhibited the features of the so called immunoblastic lymphadenopathy. The histological and clinical findings allow to distinguish the disease from both the malignant lymphomas and other forms of benign pseudolymphomas. The most important clinical features are severe general symptoms, generalised lymphadenopathy, hepatosplenomegaly, skin rash and a variety of abnormal reactions in the B-cell system such as hypergammaglobulinaemia, a transient positive Coombs test and the appearance of plasma cells in the peripheral blood. Evidence for a neoplastic nature of the disease is lacking. Nevertheless, the course of the disease may be progressive and fatal, but spontaneous remissions and subsequent relapses have also been essential part of the therapeutic strategy. Immunosupressants such as corticosteroids may have a positive effect in cases with immunological complications.

Entities:  

Mesh:

Year:  1977        PMID: 557703     DOI: 10.1007/bf01484727

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  17 in total

1.  Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin's disease.

Authors:  R J Lukes; B H Tindle
Journal:  N Engl J Med       Date:  1975-01-02       Impact factor: 91.245

2.  [Lupus erythematosus-like syndrome with antimitochondrial antibodies].

Authors:  D Maas; H Schubothe
Journal:  Dtsch Med Wochenschr       Date:  1973-01-26       Impact factor: 0.628

Review 3.  Lymphadenopathy simulating the malignant lymphomas.

Authors:  R F Dorfman; R Warnke
Journal:  Hum Pathol       Date:  1974-09       Impact factor: 3.466

4.  An immunofluorescence procedure for the detection of intracellular immunoglobulins.

Authors:  W Hijmans; H R Schuit; F Klein
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

5.  [Hodgkin's disease with constantly high content of epithelioid cells].

Authors:  K Lennert; J Mestdagh
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1968

6.  Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.

Authors:  K K Mittal; M R Mickey; D P Singal; P I Terasaki
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

7.  Letter: Angio-immunoblastic lymphadenopathy with dysproteinaemia.

Authors:  H T Abu-Zahra; D B McDonald
Journal:  Lancet       Date:  1975-01-11       Impact factor: 79.321

8.  [Rapidly debilitating disease with generalized lymphadenopathy, skin involvement and interstitial pulmonary infiltration (report of three cases)].

Authors:  O Haferkamp; W Schachenmayr; U R Kleeberg; A Wildfeuer; K Borowski; H Meister; N Konietzko; J Engels; K H Schrewe
Journal:  Dtsch Med Wochenschr       Date:  1975-02-21       Impact factor: 0.628

9.  [Immunoblastic lymphadenopathy with a pseudoleukemic blood picture].

Authors:  A Schoengen; M Dietrich; B Kubanek; O Haferkamp; H Heimpel
Journal:  Blut       Date:  1976-01

10.  Letter: Immunoblactic lymphadenopathy associated with phenytoin (diphenylhydantoin).

Authors:  M J Lapes; R J Vivacqua; K Antoniades
Journal:  Lancet       Date:  1976-01-24       Impact factor: 79.321

View more
  5 in total

1.  [Disease-specific renal failure in angioimmunoblastic lymphadenopathy - remission by high dose prednisolone. A case report (author's transl)].

Authors:  E Platzer; R von Roemeling; B Kaduk; U Meinl
Journal:  Klin Wochenschr       Date:  1981-05-15

2.  [Angioimmunoblastic lymphadenopathy and persistent virus infection? Discussion of immunohistological findings on two cases (author's trsnsl)].

Authors:  M Bergholz; H H Bartsch; G R Krueger; A Schauer; R Fischer
Journal:  Klin Wochenschr       Date:  1979-12-17

3.  Blood findings in lymphogranulomatosis X.

Authors:  R Zankowich; M R Parwaresch; K Lennert
Journal:  Blut       Date:  1984-02

4.  Malignant progression of angioimmunoblastic lymphadenopathy.

Authors:  M Bamberg; K Donhuijsen; P G Höher; H Holfeld; D K Hossfeld
Journal:  J Cancer Res Clin Oncol       Date:  1979-04-12       Impact factor: 4.553

5.  Rubella virus antigen in lymphocytes of patients with angioimmunoblastic lymphadenopathy (AIL).

Authors:  G R Krueger; M Bergholz; H H Bartsch; R Fischer; A Schauer
Journal:  J Cancer Res Clin Oncol       Date:  1979-09       Impact factor: 4.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.